MAS1 and hypertrophy: Angiotensin II is the major effector via activation of angiotensin II receptors which initiate downstream pathways leading to apoptosis, cardiac hypertrophy and fibrotic remodeling (38), whereas Angiotensin-(1–7), and Mas1 activation contribute to cardioprotection (39).